Pfizer, Inc.
December 1, 2016
Oral Health and Dental Management for the Pregnant and Lactating PatientThis course will present the oral manifestations that may be encountered in pregnancy. Many myths re…
November 15, 2016
YOU, ME AND H.PYLORI: Gastrointestinal Diseases and Their Dental ImplicationsChronic gastric disorders are some of the most common systemic diseases encountered in our patients.
October 10, 2016
Fighting Dental Caries and BeyondThis course will cover the caries process over time including the Caries Continuum including the imp…
September 20, 2016
The Art and Science of Mechanically Controlling PlaqueOur goal is to inform about the process of oral hygiene and to arm pharmacists with an understanding…
September 15, 2016
Anatomy of Toothpaste ExposedThis program will provide participants with an insight view of toothpaste. It will include a overvie…
July 5, 2016
Oral Malodor: A Review of Key principlesThis presentation will provide an examination and diagnosis of oral malodor including a comprehensiv…
July 1, 2016
Heart Disease: The #1 Killer!This course will look at risk factors for, and strategies for the prevention of, heart disease.
July 1, 2016
Oral health and pulmonary diseaseRecent research suggests an association between poor oral health status and pulmonary diseases such…
July 1, 2016
Ending the Disease of Tobacco AddictionThis webinar provides empirical evidence for safe and effective treatment for the condition of addic…
October 7, 2016 | Clinical
Infection control in dentistry has never been more essentialDemand for dental treatment has been increasing in recent years as people have become more aware of their oral health and the benefits of good dental aesthetics. Maintaining and practising …
read article
September 29, 2016 | Business
Pfizer close to acquisition of MedivationNEW YORK, USA: Pfizer has announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired with respect to Pfizer’s pending acquisition of Medivation. Pfizer now …
read article
September 30, 2016 | News
Broadly neutralising HIV antibodies could drive development of vaccineZURICH, Switzerland: A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against …
read article
October 13, 2016 | Business
Bayer and DelSiTech to develop innovative drug delivery technologyBERLIN, Germany: Bayer and DelSiTech, a Finnish drug delivery technology and drug development company, have signed a Collaboration and Technology Licence Agreement for the worldwide application of DelSiTech’s Silica Matrix …
read article